{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/candida-skin/background-information/complications-prognosis/","result":{"pageContext":{"chapter":{"id":"16b02723-03c7-5877-8f98-955d9ba0adda","slug":"complications-prognosis","fullItemName":"Complications and prognosis","depth":2,"htmlHeader":"<!-- begin field 199d5d07-dd7b-482c-b3f8-a76000b4b208 --><h2>What are the complications and prognosis of candidal skin infections?</h2><!-- end field 199d5d07-dd7b-482c-b3f8-a76000b4b208 -->","summary":"","htmlStringContent":"<!-- begin item 5e17e923-1cb2-4732-b193-a76000b4b27e --><!-- begin field 48bf422c-c7f4-413c-8678-a76000b4b208 --><ul><li><strong>Complications of candidal skin infection include </strong>soreness and itching (which may be severe). In people who are severely immunocompromised, the<strong> </strong>infection can become blood borne, leading to systemic/invasive candidiasis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Akpan and Morgan, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">BMJ, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">CDC, 2017</a>].<ul><li>Candidemia (the presence of <em>Candida</em> species in the blood) is the most common manifestations of invasive candidiasis, with an estimated mortality rate of 19–30% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">CDC, 2017</a>].</li><li>Systemic/invasive candidiasis is a serious infection which can affect the heart, central nrevous system, eyes, bones, and joints, leading to sepsis and/or organ-specific infections (such as pneumonia; meningitis; endocarditis; and mucocutaneous, osteoarticular, hepatosplenic, and peritoneal infections). It has an estimated mortality rate of up to 79% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Akpan and Morgan, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Patil, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Primary Care Dermatology Society, 2016a</a>].</li></ul></li><li><strong>The clinical course of a candidal infection depends on the type of candidiasis and the presence of any associated <a class=\"topic-reference internal-reference\" href=\"/topics/candida-skin/background-information/causes-risk-factors/\">disorders or risk factors</a></strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">BMJ, 2017</a>]<strong>.</strong><ul><li>For most people, untreated candidiasis persists for months or years unless associated risk factors are treated or eliminated. </li></ul></li></ul><!-- end field 48bf422c-c7f4-413c-8678-a76000b4b208 --><!-- end item 5e17e923-1cb2-4732-b193-a76000b4b27e -->","topic":{"id":"0d4d1ca9-1f95-59a6-9163-91faf2fce35e","topicId":"44d93cc7-56e9-4f35-92ee-6fe5c97d5646","topicName":"Candida - skin","slug":"candida-skin","lastRevised":"Last revised in May 2017","chapters":[{"id":"fdd77154-68fd-5e12-ab34-4980d82ec2e8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"20e27b79-2755-56d0-811f-79d59b1ad973","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"dc171785-2e5e-50c2-9f57-0cd56c75a2d7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"9ce37f9c-5801-5953-acaa-da119b97818f","slug":"changes","fullItemName":"Changes"},{"id":"a9f51671-bb82-536e-9b5f-c98cb41291e6","slug":"update","fullItemName":"Update"}]},{"id":"6f439137-5e54-571e-b7aa-8cce9c5c58f6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7433f221-a6d1-5f98-a53d-32009abd6d65","slug":"goals","fullItemName":"Goals"},{"id":"c1df0f9d-1fa3-5aa3-96a3-7636250c141a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1edcd62f-0185-5317-a25a-afb5e18d3d5e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e514a54c-ae49-5bb6-9c8e-0de16f244409","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"00336847-83a8-540e-954e-23801c8eb472","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"99dacab6-3fed-5a48-ad05-74876122fa41","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7884dd9b-ba26-56fe-8b96-29022de73f28","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3aa00866-7e3b-5a84-9b01-091a915acd1e","slug":"definition","fullItemName":"Definition"},{"id":"82ae2b5c-db02-50a0-9572-a12b245c9f9f","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"16b02723-03c7-5877-8f98-955d9ba0adda","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"3e942288-d611-5acc-a0a5-79c5a9bbf5c3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"815a9379-3ee5-585a-997e-8daf2e138d95","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"556293f9-6cf5-5f40-bdd2-06dfff1c5b82","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d48752d8-0979-5908-b55c-40d0bf50e947","fullItemName":"Management","slug":"management","subChapters":[{"id":"187d27a6-4a3a-59f4-99c1-33a221ca0d2b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ab1b23e6-6d8b-5003-bdea-20df2a09e2b1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"216d1aaa-ae60-548d-b753-0c53f672a4ad","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"a6376d8b-e282-52b4-a990-ceb7d73afaf3","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"}]},{"id":"1b822a63-5645-5cdc-9a82-7e61da577351","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6bcfeaf8-f78c-5867-99f3-adb4fde508db","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e9a0750e-9090-547a-aac2-eea9118c16c8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7624a8b0-8f03-5842-b47f-0374a546f628","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e3980da9-5b2b-5ebb-a7ed-7edcff958155","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e3941da5-da7c-5313-b272-7df5b0bd2985","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"0839e574-758e-59d0-8520-6335161c5e49","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3603b783-48c3-58d3-a191-1fb1ff30eca8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7884dd9b-ba26-56fe-8b96-29022de73f28","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}